Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab.

Authors
Type
Published Article
Journal
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Publication Date
Volume
28
Issue
2
Pages
202–204
Identifiers
DOI: 10.1089/jop.2011.0140
PMID: 22149640
Source
Medline
License
Unknown

Abstract

Intravitreal bevacizumab is effective in producing juxtafoveal CNV stabilization and visual acuity improvement in a patient affected by RP, over a 12-month follow-up. Future studies are required to ascertain the best therapeutic approach for CNV complicating RP.

Statistics

Seen <100 times